Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

06833 Sinco Pharmaceuticals

0.275
+0.032+13.17%
Closed 09/30 16:08 CCT
High
0.285
Open
0.245
Turnover
2.97M
Low
0.245
Pre Close
0.243
Volume
11.16M
Market Cap
559.04M
P/E(TTM)
3.82
52wk High
2.320
Shares
2.03B
P/E(Static)
3.40
52wk Low
0.183
Float Cap
559.04M
Bid/Ask %
-62.08%
Historical High
2.320
Shs Float
2.03B
Volume Ratio
1.69
Historical Low
0.146
Dividend TTM
--
Div Yield TTM
--
P/B
0.80
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.55%
Amplitude
16.46%
Avg Price
0.266
Lot Size
4000
Float Cap
559.04M
Bid/Ask %
-62.08%
Historical High
2.320
Shs Float
2.03B
Volume Ratio
1.69
Historical Low
0.146
Dividend TTM
--
P/B
0.80
Dividend LFY
--
Turnover Ratio
0.55%
Amplitude
16.46%
Avg Price
0.266
Lot Size
4000
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Xingke Rong Pharmaceutical Holdings Co., Ltd. mainly provides marketing, promotion and channel management (MPCM) services in the pharmaceutical industry of the people's Republic of China. The company provides comprehensive MPCM services to small and medium-sized overseas pharmaceutical manufacturers that do not have independent marketing and promotion capabilities in China. Its main product is human serum albumin injection. The product is a human serum albumin produced by Octapharma for the treatment of hypovolemic and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, as well as the prevention and treatment of hypoalbuminemia and neonatal hyperbilirubinemia. In addition, its products include Ankexin, McDonnell, Elsaif, Tate and Torot and so on.
CEO: Xiangbin Huang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...